Related Experiment Video
Updated: Aug 2, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Post-cardiac transplantation gout: incidence of therapeutic complications
A E Wluka1, P F Ryan, A M Miller
1Rheumatology Unit, Alfred Hospital, Melbourne, Australia. anita.wluka@med.monash.edu.au
Insights
Gout treatment in cardiac transplant patients carries significant risks, including serious complications like pancytopenia and neuromyopathy. Careful management is crucial for patient health and immunosuppression effectiveness.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Gout is a common comorbidity in patients with end-stage renal disease.
- Cardiac transplantation is a life-saving procedure for eligible patients.
- Management of gout in transplant recipients requires careful consideration of potential drug interactions and side effects.
Purpose of the Study:
- To investigate the clinical outcomes and complications associated with gout treatment in patients who have undergone cardiac transplantation.
- To assess the impact of gout pharmacotherapy on the health and immunosuppressive regimens of cardiac transplant recipients.
Main Methods:
- A retrospective audit was conducted on cardiac transplant recipients at Alfred Hospital before August 1998.
- Patient data, including pre-transplant and post-transplant gout diagnoses and treatments, were analyzed.
- Complications arising from gout medications such as allopurinol, colchicine, and NSAIDs were documented.
Main Results:
- Out of 225 patients, 19% had pre-transplant gout, and 19% experienced recurring gout post-transplantation. 23 patients developed de novo gout.
- Allopurinol use led to pancytopenia in 6 out of 24 patients, necessitating hospitalization and changes in immunosuppression.
- Colchicine treatment resulted in neuromyopathy in 5 out of 32 patients, with impaired renal function, diuretic use, and hypertension being more prevalent in this group.
- Non-steroidal anti-inflammatory agents (NSAIDs) caused severe gastrointestinal complications in one patient, leading to chronic renal failure.
Conclusions:
- Cardiac transplant recipients are at a high risk of developing serious therapeutic complications when treated for gout.
- Gout treatment significantly impacts the overall care, health status, and immunosuppressive management of these vulnerable patients.
- Close monitoring and individualized treatment strategies are essential for managing gout in cardiac transplant recipients to mitigate risks.
Objective:
To study the clinical impact of gout treatment following cardiac transplantation.
Methods:
We performed an audit of all cardiac transplant recipients of the Alfred Hospital before August 1998 who lived in Victoria.
Results:
We studied 225 patients (81% men), with a mean post-transplant follow-up of 50.8 months (SD 36). Forty-three (19%) had pre-transplant gout, 19 recurring post-transplantation. Twenty-three patients developed gout de novo. Of the 24 patients who received allopurinol, 6 developed pancytopenia and required hospitalization. Fourteen received a change in immunosuppression: in 5 patients following pancytopenia, and in 9 to enable safe use of allopurinol. Thirty-two patients received colchicine; 5 developed neuromyopathy. Impaired renal function, diuretic use, and hypertension were more common in this sub-group. Non-steroidal anti-inflammatory agents, used in 16 patients, caused serious complications in 1 patient (life-threatening peptic ulceration and hemorrhage, precipitating dialysis-dependent chronic renal failure).
Conclusions:
Cardiac transplant recipients, when treated for gout, are at high risk of therapeutic complications. Thus, gout treatment significantly affects care, health, and immunosuppression of these patients.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease V: Postoperative Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

